Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

DX

Dynex Capital Names Michael Sartori New CFO

Dynex Capital, Inc. has announced the appointment of Michael Sartori as its new Chief Financial Officer, succeeding Robert Colligan who is leaving the role by mutual agreement. Sartori, who has been with the company for over ten years, brings a strong foundation in accounting and corporate finance, coupled with expertise in capital markets and financial planning and analysis.

Under Colligan's leadership, Dynex Capital has experienced exponential growth and has maintained its status as one of the best-performing mortgage REITs this decade. Colligan has been instrumental in instilling professionalism, rigor, and transparency in the company's financial reporting processes, leading to top-tier returns and growth in the company's capital base.

Sartori, in his most recent role as head of capital markets and FP&A, has been responsible for overseeing the identification and monitoring of performance drivers for the company and its investment products. He has also played a key role in developing financial models to analyze potential transactions and reviewing capital structure alternatives.

To facilitate a smooth transition, Colligan has agreed to remain with the company in an advisory role through May 1, 2026. His departure is unrelated to the company's financial reporting or controls.

Dynex Capital, Inc. (NYSE: DX) is a leading internally managed REIT with a long track record of delivering attractive dividends through disciplined risk management of investments in high-quality mortgage assets backed by U.S. residential and commercial real estate.

Following these announcements, the company's shares moved 2.73%, and are now trading at a price of $14.65. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS